{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:45:34Z","timestamp":1777293934552,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1053\/j.semnuclmed.2024.11.005","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T12:28:37Z","timestamp":1734092917000},"page":"387-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Radiomics and Artificial Intelligence Landscape for [18F]FDG PET\/CT in Multiple Myeloma"],"prefix":"10.1053","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8739-8741","authenticated-orcid":false,"given":"Christos","family":"Sachpekidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0263-8820","authenticated-orcid":false,"given":"Lars","family":"Edenbrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0338-9472","authenticated-orcid":false,"given":"Antonia","family":"Dimitrakopoulou-Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.semnuclmed.2024.11.005_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0002","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1200\/EDBK_159074","article-title":"The role of imaging in the treatment of patients with multiple myeloma in 2016","volume":"35","author":"Terpos","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.11.005_bib0003","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","article-title":"Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: A consensus statement by the International Myeloma Working Group","volume":"18","author":"Cavo","year":"2017","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.11.005_bib0004","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/blood-2018-08-825356","article-title":"Imaging in multiple myeloma: how? When?","volume":"133","author":"Zamagni","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.11.005_bib0005","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.11.005_bib0006","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","article-title":"Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group","volume":"18","author":"Cavo","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.11.005_bib0007","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders","volume":"20","author":"Hillengass","year":"2019","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.11.005_bib0008","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.semnuclmed.2015.02.006","article-title":"Pitfalls and artifacts in the use of PET\/CT in oncology imaging","volume":"45","author":"Corrigan","year":"2015","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0009","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/bjh.12007","article-title":"The role of imaging techniques in the management of multiple myeloma","volume":"159","author":"Zamagni","year":"2012","journal-title":"Br. J. Haematol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.11.005_bib0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2017-03-774422","article-title":"Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma","volume":"130","author":"Rasche","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.11.005_bib0011","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00259-015-3200-9","article-title":"Image interpretation criteria for FDG PET\/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe)","volume":"43","author":"Nanni","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.11.005_bib0012","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00259-017-3909-8","article-title":"Interpretation criteria for FDG PET\/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)","volume":"45","author":"Nanni","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0013","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2967\/jnumed.112.106500","article-title":"Metabolic tumor volume assessed by 18F-FDG PET\/CT for the prediction of outcome in patients with multiple myeloma","volume":"53","author":"Fonti","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0014","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1158\/1078-0432.CCR-16-0235","article-title":"Assessment of total lesion glycolysis by (18)F FDG PET\/CT significantly improves prognostic value of GEP and ISS in myeloma","volume":"23","author":"McDonald","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.11.005_bib0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00277-019-03852-2","article-title":"Visual and volumetric parameters by 18F-FDG-PET\/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma","volume":"99","author":"Fonti","year":"2020","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.11.005_bib0016","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/bjh.16633","article-title":"Pre-treatment metabolic tumour volume and total lesion glycolysis are superior to conventional positron-emission tomography\/computed tomography variables for outcome prediction in patients with newly diagnosed multiple myeloma in clinical practice","volume":"191","author":"Terao","year":"2020","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.11.005_bib0017","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.3324\/haematol.2018.213041","article-title":"Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography\/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma","volume":"104","author":"Sachpekidis","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.11.005_bib0018","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.11.005_bib0019","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","article-title":"Radiomics: the process and the challenges","volume":"30","author":"Kumar","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0020","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.11.005_bib0021","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.ro.2023.02.002","article-title":"Introduction to radiomics and artificial intelligence: a primer for radiologists","volume":"58","author":"Haneberg","year":"2023","journal-title":"Semin Roentgenol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.11.005_bib0022","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacr.2017.09.044","article-title":"Machine Learning in radiology: applications beyond image interpretation","volume":"15","author":"Lakhani","year":"2018","journal-title":"J Am Coll Radiol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.11.005_bib0023","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1007\/s00259-019-04383-8","article-title":"Global disease score (GDS) is the name of the game!","volume":"46","author":"H\u00f8ilund-Carlsen","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.11.005_bib0024","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/neuonc\/noaa232","article-title":"Brain metastasis detection using machine learning: a systematic review and meta-analysis","volume":"23","author":"Cho","year":"2021","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.11.005_bib0025","doi-asserted-by":"crossref","first-page":"15814","DOI":"10.1038\/s41598-021-95249-3","article-title":"Deep learning for pulmonary embolism detection on computed tomography pulmonary angiogram: a systematic review and meta-analysis","volume":"11","author":"Soffer","year":"2021","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110073","article-title":"Convolutional neural network performance compared to radiologists in detecting intracranial hemorrhage from brain computed tomography: a systematic review and meta-analysis","volume":"146","author":"Daugaard J\u00f8rgensen","year":"2022","journal-title":"Eur J Radiol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2024.11.005_bib0027","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1007\/s00330-022-08784-6","article-title":"Radiology artificial intelligence: a systematic review and evaluation of methods (RAISE)","volume":"32","author":"Kelly","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110247","article-title":"Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis","volume":"150","author":"Liang","year":"2022","journal-title":"Eur J Radiol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2024.11.005_bib0029","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/MNM.0000000000001437","article-title":"Improved 18-FDG PET\/CT diagnosis of multiple myeloma diffuse disease by radiomics analysis","volume":"42","author":"Mesguich","year":"2021","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.874847","article-title":"Application of 18F-FDG PET-CT images based radiomics in identifying vertebral multiple myeloma and bone metastases","volume":"9","author":"Jin","year":"2022","journal-title":"Front Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.11.005_bib0031","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1007\/s00259-023-06339-5","article-title":"Application of an artificial intelligence-based tool in [18F]FDG PET\/CT for the assessment of bone marrow involvement in multiple myeloma","volume":"50","author":"Sachpekidis","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.11.005_bib0032","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40658-020-00316-9","article-title":"RECOMIA-a cloud-based platform for artificial intelligence research in nuclear medicine and radiology","volume":"7","author":"Tr\u00e4g\u00e5rdh","year":"2020","journal-title":"EJNMMI Phys"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.11.005_bib0033","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MNM.0000000000001809","article-title":"The added diagnostic value of 18 F-FDG PET\/CT radiomic analysis in multiple myeloma patients with negative visual analysis","volume":"45","author":"An","year":"2024","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.11.005_bib0034","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11548-019-02015-y","article-title":"Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosis","volume":"15","author":"Morvan","year":"2020","journal-title":"Int J Comput Assist Radiol Surg"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.11.005_bib0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00259-020-05049-6","article-title":"Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials","volume":"48","author":"Jamet","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.11.005_bib0036","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.3390\/jcm12062280","article-title":"Machine learning model based on optimized radiomics feature from 18F-FDG-PET\/CT and clinical characteristics predicts prognosis of multiple myeloma: A preliminary study","volume":"12","author":"Ni","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.11.005_bib0037","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1038\/s41598-023-34653-3","article-title":"Cluster analysis of autoencoder-extracted FDG PET\/CT features identifies multiple myeloma patients with poor prognosis","volume":"13","author":"Lee","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.11.005_bib0038","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12880-023-01033-2","article-title":"18FFDG PET\/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple myeloma","volume":"23","author":"Zhong","year":"2023","journal-title":"BMC Med Imaging"},{"issue":"8","key":"10.1053\/j.semnuclmed.2024.11.005_bib0039","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00259-024-06668-z","article-title":"Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET\/CT predicts survival in multiple myeloma","volume":"51","author":"Sachpekidis","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0040","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1200\/JCO.2016.69.2517","article-title":"Depth of response in multiple myeloma: a pooled analysis of three PETHEMA\/GEM clinical trials","volume":"35","author":"Lahuerta","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0041","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamaoncol.2016.3160","article-title":"Association of minimal residual disease with superior survival outcomes in patients with multiple myeloma: a meta-analysis","volume":"3","author":"Munshi","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0042","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1200\/JCO.19.01231","article-title":"Measurable residual disease by next-generation flow cytometry in multiple myeloma","volume":"38","author":"Paiva","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0043","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1182\/blood-2018-06-858613","article-title":"Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma","volume":"132","author":"Perrot","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0044","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0045","doi-asserted-by":"crossref","first-page":"15086","DOI":"10.1038\/ncomms15086","article-title":"Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates","volume":"8","author":"Kis","year":"2017","journal-title":"Nat Commun"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0046","doi-asserted-by":"crossref","first-page":"363ra147","DOI":"10.1126\/scitranslmed.aac7037","article-title":"Genetic interrogation of circulating multiple myeloma cells at single-cell resolution","volume":"8","author":"Lohr","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0047","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","article-title":"Spatial genomic heterogeneity in multiple mye- loma revealed by multi-region sequencing","volume":"8","author":"Rasche","year":"2017","journal-title":"Nat Commun"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0048","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1182\/blood-2015-12-686782","article-title":"Spatially divergent clonal evolution in multiple myeloma: Overcoming resistance to BRAF inhibition","volume":"127","author":"Raab","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.11.005_bib0049","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1038\/s41467-023-40584-4","article-title":"Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level","volume":"14","author":"John","year":"2023","journal-title":"Nat Commun"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0050","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/s41375-018-0329-0","article-title":"Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma","volume":"33","author":"Rasche","year":"2019","journal-title":"Leukemia"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102017","article-title":"Impact of minimal residual disease standardised assessment by FDG-PET\/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial","volume":"60","author":"Zamagni","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1053\/j.semnuclmed.2024.11.005_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2022.107083","article-title":"Bone marrow segmentation and radiomics analysis of [18F]FDG PET\/CT images for measurable residual disease assessment in multiple myeloma","volume":"225","author":"Milara","year":"2022","journal-title":"Comput Methods Programs Biomed"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.11.005_bib0053","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s13246-023-01265-0","article-title":"Radiomics analysis of bone marrow biopsy locations in [18F]FDG PET\/CT images for measurable residual disease assessment in multiple myeloma","volume":"46","author":"Milara","year":"2023","journal-title":"Phys Eng Sci Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299824001119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299824001119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:32:51Z","timestamp":1744677171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299824001119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0001299824001119"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.11.005","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiomics and Artificial Intelligence Landscape for [18F]FDG PET\/CT in Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}